Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $-475874.00.
ENTERPRISE VALUE (EV)
$-475874.00
Cadrenal Therapeutics, Inc. Common Stock
Market Cap
$3.53M
Enterprise Value (EV)
$-475874.00
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Cadrenal Therapeutics, Inc. Common Stock (CVKD) | $3.53M | $-475874.00 |
| Moolec Science S.A. (MLEC)vs › | $3.50M | N/A |
| Eocene Ltd. (EOCN)vs › | $3.50M | N/A |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | N/A |
| WORK Medical Technology Group Ltd. Class A (WOK)vs › | $3.63M | $7.00M |
| Ernexa Therapeutics Inc. (ERNA)vs › | $3.65M | N/A |
| Evogene Ltd. (EVGN)vs › | $3.65M | N/A |
| Nexalin Technology, Inc. (NXL)vs › | $3.30M | $2.30M |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.28M | N/A |
| MBody AI Ltd. (MBAI)vs › | $3.25M | $3.26M |
Market Cap
$3.53M
Total Debt
$0.00
Cash
$4.01M
Enterprise Value
$-475874.00
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
